BIONOMICS LIMITED - AM
0.4030
08-November-24 11:46:48
15 minutes delayed
Stocks
+0.0230
+6.05%
Today's range
0.3402 - 0.4700
ISIN
N/A
Source
NASDAQ
-
23 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
31 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
03 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics to Present at Upcoming June Investor Conferences
15 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
30 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
28 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
27 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
08 Mar 2023 19:00:30 By Nasdaq GlobeNewswire
-
23 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
30 Jan 2023 18:23:46 By Nasdaq GlobeNewswire
-
Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety Disorder
18 Dec 2022 19:34:26 By Nasdaq GlobeNewswire
-
Bionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive Officer
15 Dec 2022 18:35:25 By Nasdaq GlobeNewswire
-
02 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
21 Nov 2022 18:13:51 By Nasdaq GlobeNewswire
-
16 Nov 2022 18:36:15 By Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in Upcoming November Investor Conferences
02 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Quarterly Activities Report for September 2022
25 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million
18 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
04 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
21 Sep 2022 06:00:00 By Nasdaq GlobeNewswire